Electronic Trial Master File Systems Market Analysis Report 2024: Rising Adoption of eTMF Solutions Spurs Growth Amid Surge in Clinical Trials – Global Forecast to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Electronic Trial Master File Systems Market Size, Share & Trends Analysis Report By Delivery Mode (Cloud & Web-based, On-premise), By Clinical Trials (Phase I, Phase II), By End-use, By Region, And Segment Forecasts, 2024 – 2030” report has been added to ResearchAndMarkets.com’s offering.

The global electronic trial master file systems market size is estimated to reach USD 1.9 billion by 2030, registering a CAGR of 14.7% from 2024 to 2030

The market growth is attributed to a stringent regulatory structure for clinical trials and a heightened need for safety monitoring. Moreover, growing adoption of electronic trial master file (eTMF) solutions owing to the increasing number of clinical trials also contributes to the market growth. As per the data available on ClinicalTrials.gov, a total of 146,164 clinical trials were registered in the U.S., while around 259,000 studies were registered in the rest of the world in January 2024.

The COVID-19 pandemic has fueled the demand for eTMF solutions. According to an article published by Egnyte, the TMF Summit held in November 2021 highlighted the impact of COVID-19 on the clinical documentation management industry, particularly in adopting eTMFs. The pandemic compelled companies to reevaluate and embrace eTMFs and remote monitoring tools, addressing the challenges of decentralized sites and disrupted workflows. Moreover, standardization, improved user interfaces, and the integration of artificial intelligence (AI) and machine learning (ML) are anticipated to streamline data collection further, fueling the market growth over a forecast period.

Moreover, key players in the market are adopting various strategies to expand their geographical presence and strengthen their market position. For instance, in May 2023, Lotus Clinical Research expanded its partnership with Veeva Systems to adopt the Veeva Vault Clinical Suite to improve its service delivery and operational efficiency. This decision builds on Lotus’ previous use of the Vault Clinical Suite, which helped them conduct more connected and faster studies. The successful integration of Veeva Vault eTMF helped Lotus scale its trial operations while maintaining the highest quality standards.

Electronic Trial Master File Systems Market Report Highlights

• In 2023, Cloud and web-based segment dominated the market with largest revenue share of 91.3%. This is attributed to associated benefits such as easy accessibility, usability, and lower investments required
• Based on clinical trials, The Phase III segment dominated the market with largest revenue share of 53.3% in 2023. The growth of drug development sector is experiencing significant growth owing to an increasing number of drugs successfully reaching phase III
• Contract Research Organizations (CROs) segment dominated the market with the largest revenue share of 37.1% in 2023. The growing adoption of electronic trial master file solutions in research contributes to the segment growth
• North America dominated the market with the largest revenue share of 49.5 % in 2023. The market growth is attributed to an increasing target population, a rise in lifestyle-associated diseases, and the launch of new products by key market players

Company Profiles

• Oracle
• Clinevo Technologies
• MasterControl Solutions, Inc.
• Veeva Systems
• Aris Global LLC
• PHARMALEX GMBH
• TransPerfect
• Aurea, Inc.
• ePharmaSolutions (WCG Clinical)
• SureClinical Inc.
• Ennov
• Montrium Inc.
• Cloudbyz
• TRIAL INTERACTIVE
• Anju Software
• Octalsoft
• Egnyte, Inc.

Key Attributes:

Report Attribute	Details
No. of Pages	100
Forecast Period	2023 – 2030
Estimated Market Value (USD) in 2023	$728.9 Million
Forecasted Market Value (USD) by 2030	$1900 Million
Compound Annual Growth Rate	14.7%
Regions Covered	Global

Key Topics Covered:

Chapter 1 Research Methodology & Scope

1.1 Market Segmentation & Scope

1.2 Research Methodology

1.3 Information Procurement

1.4 Information or Data Analysis

1.5 Market Formulation & Validation

1.6 Model Details

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.2.1 Delivery Mode Segment Outlook

2.2.2 Clinical Trial Segment Outlook

2.2.3 End-use Segment Outlook

2.2.4 Competitive outlook

Chapter 3 Electronic Trial Master File (eTMF) Systems Market Variables Trends & Scope

3.1 Ancillary Market Analysis

3.2 Pricing Analysis

3.2.1 By delivery mode

3.2.2 By development phase

3.3 User/Buyer Perception Analysis

3.3.1 Market influencer analysis

3.3.1.1 Regulatory Requirements

3.3.1.2 Technological Developments

3.3.1.3 Product Differentiation

3.3.1.4 Demand from Consumers

3.4 Technology Overview

3.5 Regulatory Overview

3.5.1 Regulatory Landscape

3.5.1.1 List of regulations, by country

3.6 Market Dynamics

3.6.1 Market Driver Analysis

3.6.1.1 Increasing externalization of clinical trial studies by large pharmaceutical and biopharmaceutical companies

3.6.1.2 Increasing government support in the form of grants and funding

3.6.2 Market Restraints Analysis

3.6.2.1 Scarcity of skilled research professionals

3.6.2.2 Lack of recognition

3.6.3 Market Challenge Analysis

3.6.3.1 Market-related barriers

3.6.3.1.1 Lack of education and communication

3.6.3.1.2 Lack of lean processes and operations

3.7 Industry Analysis – Porter’s

3.8 Electronic Trial Master File (eTMF) Systems Market – SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)

3.9 COVID-19 Impact Analysis

Chapter 4 Electronic Trial Master File (eTMF) Systems Market: Delivery Mode Analysis

4.1 Delivery Mode Business Analysis

4.1.1 Cloud and Web-based

4.1.1.1 Cloud and web-based market estimates and forecasts, 2018 – 2030 (USD Million)

4.1.2 On-premise

Chapter 5 Electronic Trial Master File (eTMF) Systems Market: Clinical Trials Analysis

5.1 Clinical Trials Business Analysis

5.1.1 Phase I

5.1.1.1 Phase I market estimates and forecasts, 2018 – 2030 (USD Million)

5.1.2 Phase II

5.1.3 Phase III

5.1.4 Phase IV

Chapter 6 Electronic Trial Master File (eTMF) Systems Market: End-use Analysis

6.1 End-use Business Analysis

6.1.1 Hospitals/healthcare providers

6.1.1.1 Hospitals market estimates and forecasts, 2018 – 2030 (USD Million)

6.1.2 Contract Research Organizations (CROs)

6.1.3 Academic institutes

6.1.4 Pharma & biotech organizations

6.1.5 Medical device manufacturers

Chapter 7 Electronic Trial Master File (eTMF) Systems Market: Regional Market Analysis, By Delivery Mode, By Clinical Trials, and By End-use, 2018 – 2030 (USD Million)

7.1 Regional Market Share Analysis, 2023 & 2030

7.2 Regional Market Snapshot

Chapter 8 Electronic Trial Master File (eTMF) Systems Market: Competitive Landscape

8.1 Company Categorization

8.2 Participants’ Overview

8.3 Financial Performance

8.3.1 Electronic Trial Master File (eTMF) Systems Market

8.3.1.1 Public Market Players

8.3.1.2 Private Market Players

8.4 Product Benchmarking

8.4.1 Electronic Trial Master File (eTMF) Systems Market

8.5 Heat Map Analysis

8.5.1 Electronic Trial Master File (eTMF) Systems Market-Heat Map Analysis

8.6 Electronic trial master file (eTMF) systems market: Company market share analysis, 2023

8.7 Strategy Mapping

8.7.1 Electronic Trial Master File (eTMF) Systems Market

8.7.1.1 Collaborations/Partnership

8.7.1.2 New Product Launches

8.7.1.3 Mergers/Acquisitions

8.7.1.4 Others

8.8 List of Other Companies

Chapter 9 KOL Recommendations/Conclusion

Chapter 10 Survey insights/Use cases

For more information about this report visit https://www.researchandmarkets.com/r/czgfbk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900